Arcadia Biosciences (RKDA) Assets Average (2015 - 2025)

Arcadia Biosciences' Assets Average history runs 11 years deep, the most recent figure standing at $7.6 million for Q4 2025.

• Quarterly Assets Average fell 47.39% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (down 47.39% YoY) and the FY2025 annual result came in at $10.0 million, down 39.61% from the prior year.
• Assets Average was $7.6 million for Q4 2025 at Arcadia Biosciences, down from $8.2 million in the prior quarter.
• Across five years, Assets Average topped out at $70.8 million in Q2 2021 and bottomed at $7.6 million in Q4 2025.
• A 5-year average of $30.0 million and a median of $26.9 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average jumped 102.21% — and 2025, when it slumped 49.79%.
• Arcadia Biosciences' Assets Average stood at $51.6 million in 2021, then plunged by 38.54% to $31.7 million in 2022, then sank by 31.9% to $21.6 million in 2023, then slumped by 33.39% to $14.4 million in 2024, then sank by 47.39% to $7.6 million in 2025.
• Business Quant data shows RKDA's Assets Average at $7.6 million in Q4 2025, $8.2 million in Q3 2025, and $10.4 million in Q2 2025.